Melva Gajeton Devera, MD | |
3241 Lakeland Hills Blvd, Lakeland, FL 33805-2266 | |
(863) 413-2620 | |
(863) 499-2612 |
Full Name | Melva Gajeton Devera |
---|---|
Gender | Female |
Speciality | General Practice |
Location | 3241 Lakeland Hills Blvd, Lakeland, Florida |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528056082 | NPI | - | NPPES |
255121700 | Medicaid | FL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | ME49999 (Florida) | Primary |
Entity Name | Florida Department Of Health |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396732541 PECOS PAC ID: 3072424282 Enrollment ID: O20100517000771 |
News Archive
AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source.
Five articles, whose lead or senior authors are nationally known informatics leaders and members of the American Medical Informatics Association (AMIA), appear in the Feb. 2010 issue of Health Affairs and provide a glimpse into the future of health care delivery in an increasingly information-driven era of health care in the developing world.
Football scores from all angles for untrained middle-aged and elderly women and men with prediabetes. This is the conclusion from a study carried out in the Faroe Islands by football researchers and physiologists from the Department of Sports Science and Clinical Biomechanics at the University of Southern Denmark and the University of the Faroe Islands.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $47.4 million through the public offering of 2,750,000 newly issued shares of its common stock at a price of $17.25 per share. All of the shares are being offered by Clinical Data, Inc.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Melva Gajeton Devera, MD 1290 Golfview Ave, Attn: Billing Department, Bartow, FL 33830-6738 Ph: (863) 519-7900 | Melva Gajeton Devera, MD 3241 Lakeland Hills Blvd, Lakeland, FL 33805-2266 Ph: (863) 413-2620 |
News Archive
AstraZeneca today asked the U.S. Food and Drug Administration (FDA) to adopt guidance that will enable AstraZeneca and others to fully engage in real-time, social media conversations that responsibly provide accurate, balanced information on medicines from a known, identifiable and reliable source.
Five articles, whose lead or senior authors are nationally known informatics leaders and members of the American Medical Informatics Association (AMIA), appear in the Feb. 2010 issue of Health Affairs and provide a glimpse into the future of health care delivery in an increasingly information-driven era of health care in the developing world.
Football scores from all angles for untrained middle-aged and elderly women and men with prediabetes. This is the conclusion from a study carried out in the Faroe Islands by football researchers and physiologists from the Department of Sports Science and Clinical Biomechanics at the University of Southern Denmark and the University of the Faroe Islands.
Results from a recent preclinical study have shown that a new drug combination therapy being developed at Virginia Commonwealth University Massey Cancer Center effectively killed colon, liver, lung, kidney, breast and brain cancer cells while having little effect on noncancerous cells. The results lay the foundation for researchers to plan a future phase 1 clinical trial to test the safety of the therapy in a small group of patients.
Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $47.4 million through the public offering of 2,750,000 newly issued shares of its common stock at a price of $17.25 per share. All of the shares are being offered by Clinical Data, Inc.
› Verified 7 days ago
Janmary Figueroa, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 206 N Florida Ave, Lakeland, FL 33801 Phone: 863-209-7003 Fax: 863-284-3083 | |
Dr. Justa Milagros Crespo Torres, MD General Practice Medicare: Medicare Enrolled Practice Location: 4120 Us Highway 98 N Ste 200, Lakeland, FL 33809 Phone: 863-940-3147 Fax: 863-940-3141 | |
Samuel Defigarelli I, M.D. General Practice Medicare: Medicare Enrolled Practice Location: 1129 N Missouri Ave, Lakeland, FL 33805 Phone: 866-234-8534 | |
Dr. Agustin Vanoni, M.D General Practice Medicare: Accepting Medicare Assignments Practice Location: 4120us Hwy 98 N. Suite 200, Lakeland, FL 33809 Phone: 863-940-3147 | |
Sarim Idrees, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 4729 Us Highway 98 S Ste 201, Lakeland, FL 33812 Phone: 863-646-9663 Fax: 863-646-9664 | |
Dr. Luis Garcia Rivera, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 5425 S Florida Ave, Lakeland, FL 33813 Phone: 863-644-3585 Fax: 863-644-3171 | |
Prudencio P Aqui, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 2133 S Combee Rd, Sterling Square, Lakeland, FL 33801 Phone: 863-666-1366 Fax: 863-667-0497 |